Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Zoetis typically reports before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-07 | -$23.91 (-21.50%) | $6.33 (5.69%) | -$4.48 (-5.13%) | $6.48 (7.42%) |
| 2026-02-12 | -$3.03 (-2.35%) | $13.55 (10.53%) | +$1.01 (+0.80%) | $5.00 (3.98%) |
| 2025-11-04 | -$19.89 (-13.78%) | $6.11 (4.23%) | -$3.97 (-3.19%) | $5.39 (4.33%) |
| 2025-08-05 | -$5.69 (-3.75%) | $15.54 (10.24%) | +$0.38 (+0.26%) | $3.05 (2.09%) |
| 2025-05-06 | -$8.19 (-5.18%) | $10.69 (6.76%) | +$6.12 (+4.08%) | $5.61 (3.74%) |
| 2025-02-13 | -$8.95 (-5.15%) | $11.72 (6.74%) | -$7.41 (-4.49%) | $8.20 (4.97%) |
| 2024-11-04 | -$6.77 (-3.72%) | $5.58 (3.07%) | +$0.09 (+0.05%) | $4.55 (2.60%) |
| 2024-08-06 | +$10.47 (+5.99%) | $5.81 (3.33%) | -$0.52 (-0.28%) | $5.72 (3.09%) |
| Avg Abs Move | 7.68% | 6.32% | 2.29% | 4.03% |
Historical price behavior around Zoetis earnings reveals significant volatility, with an average absolute Day 0 move of 7.68% and Day +1 follow-through averaging 2.29%. The most recent earnings release on May 7, 2026 produced the most dramatic reaction in the dataset, with shares plunging 21.50% on Day 0 following the Q1 miss—more than double the historical average move. Prior to that, the November 2025 report also triggered substantial downside of 13.78%, suggesting the stock has become increasingly sensitive to disappointments.
When results meet or exceed expectations, reactions have been more muted but still meaningful. The August 2024 report generated a 5.99% Day 0 gain, while other beats produced more modest initial moves in the 2-4% range. The Day 0 trading range averages 6.32%, indicating substantial intraday volatility regardless of direction. Day +1 follow-through has been less predictable, with an average absolute move of 2.29% and range of 4.03%, suggesting initial reactions often moderate or reverse in the second session. Given the heightened volatility in recent reports and the stock's current technical weakness, investors should prepare for potentially outsized moves in either direction.
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 16) |
| Expected Move | $7.57 (10.17%) |
| Expected Range | $66.83 to $81.96 |
| Implied Volatility | 71.38% |
The options market is pricing an expected move of 10.17% for the August 21 expiration, significantly higher than the historical average Day 0 move of 7.68%. This elevated implied volatility reflects heightened uncertainty following the dramatic Q1 miss and suggests options traders are positioning for another potentially large swing in either direction.
Analyst sentiment on Zoetis remains mixed, with the consensus rating at 3.94 (between Hold and Buy) and an average price target of $107.19—implying 44.1% upside from the current price of $74.39. The rating distribution shows 8 Strong Buys, 1 Moderate Buy, and 9 Holds, with no sell ratings, indicating analysts maintain long-term conviction despite near-term challenges. Price target estimates range widely from a low of $80.00 to a high of $160.00, reflecting significant disagreement about the company's recovery trajectory and valuation.
Sentiment has remained unchanged over the past month, with the same distribution of 8 Strong Buys, 1 Moderate Buy, and 9 Holds as a month ago. This stability suggests analysts are taking a wait-and-see approach rather than making dramatic revisions ahead of Q2 results. The consensus price target of $107.19 represents substantial upside from current levels, but the stock's 25% plunge following Q1 earnings has created a wide gap between analyst targets and market reality. The Street appears to be betting that current weakness represents a buying opportunity rather than a fundamental deterioration, but conviction will likely hinge on whether Q2 results can demonstrate stabilization in key business segments and validate management's full-year guidance.
Zoetis enters earnings in severe technical distress, with the Barchart Technical Opinion showing a 100% Sell signal—up from 72% Sell a week ago and matching the 100% Sell reading from a month ago. This represents maximum bearish conviction from the technical model, reflecting the stock's dramatic decline and deteriorating momentum across all timeframes.
Timeframe Analysis:
Trend Characteristics: The signal strength is Strong and Strengthening, indicating the bearish technical environment is intensifying rather than stabilizing heading into the earnings release.
The stock is trading at $74.39, below all major moving averages and showing a complete breakdown of technical support structure. Price sits below the 5-day MA ($76.17), 10-day MA ($76.31), 20-day MA ($75.85), 50-day MA ($76.91), 100-day MA ($92.45), and 200-day MA ($109.46). The widening gap between current price and longer-term moving averages—particularly the 100-day and 200-day—illustrates the severity of the breakdown. The stock is trading near its 52-week low following the May earnings disaster, with no meaningful technical support visible until the $74-75 zone where it currently trades.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $76.17 | 50-Day MA | $76.91 |
| 10-Day MA | $76.31 | 100-Day MA | $92.45 |
| 20-Day MA | $75.85 | 200-Day MA | $109.46 |
The technical setup heading into earnings is decidedly cautionary, with ZTS showing no signs of stabilization or base-building. The stock's position below all moving averages, combined with maximum bearish signals across all timeframes, suggests any disappointment could trigger further downside toward new lows. Conversely, a strong beat and improved guidance could spark a sharp relief rally given the oversold conditions and significant gap to overhead moving averages. The 50-day MA at $76.91 represents the first meaningful resistance level, while the 100-day MA at $92.45 would mark a more substantial recovery threshold. With the options market pricing a 10% move and technical indicators flashing maximum bearish warnings, the risk-reward setup favors waiting for post-earnings clarity rather than establishing positions ahead of the release.